Rhumbline Advisers Vericel Corp Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Vericel Corp stock. As of the latest transaction made, Rhumbline Advisers holds 140,454 shares of VCEL stock, worth $7.94 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

140,454

Previous 144,572 2.85%

Holding current value

$7.94 Million

Previous $6.63 Million 10.52%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$42.25 - $53.56 $173,985 - $220,560	-4,118 Reduced 2.85%	140,454 $5.93 Million
Q2 2024 Aug 01, 2024	BUY	$41.71 - $52.9 $95,807 - $121,511	2,297 Added 1.61%	144,572 $6.63 Million
Q1 2024 May 09, 2024	SELL	$32.52 - $52.33 $8,910 - $14,338	-274 Reduced 0.19%	142,275 $7.4 Million
Q4 2023 Feb 08, 2024	SELL	$30.85 - $37.09 $82,523 - $99,215	-2,675 Reduced 1.84%	142,549 $5.08 Million
Q3 2023 Nov 09, 2023	BUY	$31.69 - $39.25 $22,341 - $27,671	705 Added 0.49%	145,224 $4.87 Million
Q2 2023 Aug 08, 2023	BUY	$29.0 - $38.37 $10,440 - $13,813	360 Added 0.25%	144,519 $5.43 Million
Q1 2023 May 11, 2023	BUY	$23.85 - $31.34 $185,099 - $243,229	7,761 Added 5.69%	144,159 $4.23 Million
Q4 2022 Feb 14, 2023	BUY	$17.65 - $27.37 $115,201 - $178,643	6,527 Added 5.03%	136,398 $3.59 Million
Q3 2022 Nov 10, 2022	BUY	$22.62 - $32.54 $110,317 - $158,697	4,877 Added 3.9%	129,871 $3.01 Million
Q2 2022 Aug 11, 2022	BUY	$22.88 - $39.45 $123,185 - $212,398	5,384 Added 4.5%	124,994 $3.15 Million
Q1 2022 May 12, 2022	BUY	$31.69 - $43.29 $237,199 - $324,025	7,485 Added 6.68%	119,610 $4.57 Million
Q4 2021 Feb 10, 2022	SELL	$35.2 - $52.6 $6,019 - $8,994	-171 Reduced 0.15%	112,125 $4.41 Million
Q3 2021 Nov 12, 2021	SELL	$46.35 - $59.75 $795,736 - $1.03 Million	-17,168 Reduced 13.26%	112,296 $5.48 Million
Q2 2021 Aug 05, 2021	BUY	$47.2 - $67.81 $1.19 Million - $1.72 Million	25,316 Added 24.31%	129,464 $6.8 Million
Q1 2021 May 06, 2021	BUY	$30.93 - $59.48 $1.33 Million - $2.56 Million	43,015 Added 70.36%	104,148 $5.79 Million
Q4 2020 Feb 10, 2021	BUY	$18.53 - $31.5 $23,588 - $40,099	1,273 Added 2.13%	61,133 $1.89 Million
Q3 2020 Nov 12, 2020	SELL	$14.68 - $19.12 $210,555 - $274,238	-14,343 Reduced 19.33%	59,860 $1.11 Million
Q2 2020 Aug 13, 2020	BUY	$8.5 - $15.82 $108,256 - $201,483	12,736 Added 20.72%	74,203 $1.03 Million
Q1 2020 May 06, 2020	BUY	$7.25 - $19.22 $4,241 - $11,243	585 Added 0.96%	61,467 $564,000
Q4 2019 Feb 05, 2020	BUY	$13.77 - $19.2 $17,143 - $23,904	1,245 Added 2.09%	60,882 $1.06 Million
Q3 2019 Oct 23, 2019	BUY	$14.93 - $19.83 $477 - $634	32 Added 0.05%	59,637 $903,000
Q2 2019 Aug 14, 2019	BUY	$15.01 - $18.89 $40,226 - $50,625	2,680 Added 4.71%	59,605 $1.13 Million
Q1 2019 May 01, 2019	SELL	$16.23 - $20.29 $535 - $669	-33 Reduced 0.06%	56,925 $997,000
Q4 2018 Jan 31, 2019	BUY	$10.77 - $18.44 $230,714 - $395,021	21,422 Added 60.28%	56,958 $991,000
Q3 2018 Nov 07, 2018	BUY	$9.1 - $14.8 $4,140 - $6,734	455 Added 1.3%	35,536 $503,000
Q2 2018 Aug 06, 2018	BUY	$9.6 - $14.6 $336,777 - $512,182	35,081 New	35,081 $340,000

Others Institutions Holding VCEL

# of Institutions

276

Shares Held

48.5M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Vericel Corp Transaction History